Today, we’re very excited and honored to announce the extension of our Series C round of funding. We’ve expanded the...

Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s...

“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...